Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies
Today's Clinical Lab
Join Today's Clinical Lab and David Miklos, MD, PhD, to discuss recent advances in bispecific CAR-T therapy and biomarkers for characterizing CAR-T product quality